Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
EVERSEPT PARTNERS LP | 02-14-2023 | 12-31-2023 | 57 | 1,138,245,733 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
APELLIS PHARMACEUTICALS INC | COM | Liquidated | $0 | 0 | 0.00 | 56,449 | +Inf | 12-31-2023 | |
2SEVENTY BIO INC | COMMON STOCK | 102 | $4,864,004 | 1,139,111 | 0.00 | 1,139,111 | +Inf | 12-31-2023 | |
IMMUNOVANT INC | COM | 103 | $4,794,099 | 113,793 | 0.00 | 113,793 | +Inf | 12-31-2023 | |
KURA ONCOLOGY INC | COM | Liquidated | $0 | 0 | 0.00 | 450,622 | +Inf | 12-31-2023 |